Literature DB >> 12819349

Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis.

Douglas A Whittington1, Kristin M Rusche, Hyunshun Shin, Carol A Fierke, David W Christianson.   

Abstract

The outer leaflet of the outer membrane of the Gram-negative bacterium serves as a permeability barrier and is composed of lipopolysaccharide, also known as endotoxin. The membrane anchor of lipopolysaccharide is lipid A, the biosynthesis of which is essential for cell viability. The first committed step in lipid A biosynthesis is catalyzed by UDP-(3-O-(R-3-hydroxymyristoyl))-N-acetylglucosamine deacetylase (LpxC), a zinc-dependent deacetylase. Here we report the crystal structure of LpxC from Aquifex aeolicus, which reveals a new alpha+beta fold reflecting primordial gene duplication and fusion, as well as a new zinc-binding motif. The catalytic zinc ion resides at the base of an active-site cleft and adjacent to a hydrophobic tunnel occupied by a fatty acid. This tunnel accounts for the specificity of LpxC toward substrates and inhibitors bearing appropriately positioned 3-O-fatty acid substituents. Notably, simple inhibitors designed to target interactions in the hydrophobic tunnel bind with micromolar affinity, thereby representing a step toward the structure-based design of a potent, broad-spectrum antibacterial drug.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819349      PMCID: PMC166197          DOI: 10.1073/pnas.1432990100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

Review 2.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

3.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.

Authors:  M S Finnin; J R Donigian; A Cohen; V M Richon; R A Rifkind; P A Marks; R Breslow; N P Pavletich
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

4.  Site-directed mutagenesis of the bacterial metalloamidase UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC). Identification of the zinc binding site.

Authors:  J E Jackman; C R Raetz; C A Fierke
Journal:  Biochemistry       Date:  2001-01-16       Impact factor: 3.162

5.  Antibacterial activities and characterization of novel inhibitors of LpxC.

Authors:  John M Clements; Fanny Coignard; Ian Johnson; Stephen Chandler; Shilpa Palan; Andrew Waller; Jac Wijkmans; Michael G Hunter
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Antibacterial agents that target lipid A biosynthesis in gram-negative bacteria. Inhibition of diverse UDP-3-O-(r-3-hydroxymyristoyl)-n-acetylglucosamine deacetylases by substrate analogs containing zinc binding motifs.

Authors:  J E Jackman; C A Fierke; L N Tumey; M Pirrung; T Uchiyama; S H Tahir; O Hindsgaul; C R Raetz
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

7.  UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase of Escherichia coli is a zinc metalloenzyme.

Authors:  J E Jackman; C R Raetz; C A Fierke
Journal:  Biochemistry       Date:  1999-02-09       Impact factor: 3.162

8.  The biosynthesis of gram-negative endotoxin. Formation of lipid A precursors from UDP-GlcNAc in extracts of Escherichia coli.

Authors:  M S Anderson; C E Bulawa; C R Raetz
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

9.  Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase LpxC.

Authors:  Toni Kline; Niels H Andersen; Eric A Harwood; Jason Bowman; Andre Malanda; Stephanie Endsley; Alice L Erwin; Michael Doyle; Susan Fong; Alex L Harris; Brian Mendelsohn; Khisimuzi Mdluli; Christian R H Raetz; C Kendall Stover; Pamela R Witte; Asha Yabannavar; Shuguang Zhu
Journal:  J Med Chem       Date:  2002-07-04       Impact factor: 7.446

10.  Inhibition of the antibacterial target UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC): isoxazoline zinc amidase inhibitors bearing diverse metal binding groups.

Authors:  Michael C Pirrung; L Nathan Tumey; Christian R H Raetz; Jane E Jackman; Karnem Snehalatha; Amanda L McClerren; Carol A Fierke; Stephanie L Gantt; Kristin M Rusche
Journal:  J Med Chem       Date:  2002-09-12       Impact factor: 7.446

View more
  44 in total

1.  4D-LQTA-QSAR and docking study on potent Gram-negative specific LpxC inhibitors: a comparison to CoMFA modeling.

Authors:  Jahan B Ghasemi; Reihaneh Safavi-Sohi; Euzébio G Barbosa
Journal:  Mol Divers       Date:  2011-11-30       Impact factor: 2.943

2.  Understanding the effect of magnesium ion concentration on the catalytic activity of ribonuclease H through computation: does a third metal binding site modulate endonuclease catalysis?

Authors:  Ming-Hsun Ho; Marco De Vivo; Matteo Dal Peraro; Michael L Klein
Journal:  J Am Chem Soc       Date:  2010-10-06       Impact factor: 15.419

3.  Structure of the metal-dependent deacetylase LpxC from Yersinia enterocolitica complexed with the potent inhibitor CHIR-090 .

Authors:  Kathryn E Cole; Samuel G Gattis; Heather D Angell; Carol A Fierke; David W Christianson
Journal:  Biochemistry       Date:  2010-12-20       Impact factor: 3.162

4.  Structure and metal-dependent mechanism of peptidoglycan deacetylase, a streptococcal virulence factor.

Authors:  David E Blair; Alexander W Schüttelkopf; James I MacRae; Daan M F van Aalten
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-12       Impact factor: 11.205

5.  Mechanistic inferences from the binding of ligands to LpxC, a metal-dependent deacetylase.

Authors:  Heather A Gennadios; Douglas A Whittington; Xuechen Li; Carol A Fierke; David W Christianson
Journal:  Biochemistry       Date:  2006-07-04       Impact factor: 3.162

6.  Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa.

Authors:  Khisimuzi E Mdluli; Pamela R Witte; Toni Kline; Adam W Barb; Alice L Erwin; Bryce E Mansfield; Amanda L McClerren; Michael C Pirrung; L Nathan Tumey; Paul Warrener; Christian R H Raetz; C Kendall Stover
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

7.  Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor.

Authors:  Igor Mochalkin; John D Knafels; Sandra Lightle
Journal:  Protein Sci       Date:  2008-03       Impact factor: 6.725

8.  Discovery of new biosynthetic pathways: the lipid A story.

Authors:  Christian R H Raetz; Ziqiang Guan; Brian O Ingram; David A Six; Feng Song; Xiaoyuan Wang; Jinshi Zhao
Journal:  J Lipid Res       Date:  2008-10-29       Impact factor: 5.922

Review 9.  Structure, inhibition, and regulation of essential lipid A enzymes.

Authors:  Pei Zhou; Jinshi Zhao
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-12-09       Impact factor: 4.698

Review 10.  Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis.

Authors:  Adam W Barb; Pei Zhou
Journal:  Curr Pharm Biotechnol       Date:  2008-02       Impact factor: 2.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.